APOA1 antibody (C-Term)
Quick Overview for APOA1 antibody (C-Term) (ABIN783514)
Target
See all APOA1 AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- C-Term
-
Specificity
- This antibody detects Apolipoprotein A I (APO AI) (C-term).
-
Cross-Reactivity (Details)
- Species reactivity (tested):Human, chicken
-
Purification
- Affinity chromatography purified via peptide column
-
Immunogen
- Raised against a 19 amino acid peptide near the carboxy terminus of human ApoA1
-
-
-
-
Application Notes
- Optimal working dilution should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Buffer
- PBS containing 0.02 % sodium azide
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handling Advice
- Avoid repeated freezing and thawing.
-
Storage
- 4 °C/-20 °C
-
Storage Comment
- Store at 2 - 8 °C for up to one month or (in aliquots) at -20 °C for longer.
-
-
- APOA1 (Apolipoprotein A-I (APOA1))
-
Alternative Name
- Apolipoprotein A I (APO AI)
-
Background
- Apolipoprotein A1 (ApoA1) is the major protein component of high density lipoprotein (HDL) in plasma, which is correlated with cardiovascular disease. ApoA1 is synthesized in the liver and small intestine and promotes cholesterol efflux from tissues to the liver for excretion. It is a cofactor for lecithin cholesterolacyltransferase (LCAT), the enzyme responsible for the formation of most plasma cholesteryl esters. Defects in ApoA1 are associated with HDL deficiency, Tangier disease, and systemic non-neuropathic amyloidosis.Synonyms: APOA1, Apo-AI, ApoA-I, ApoAI
-
Gene ID
- 335
-
NCBI Accession
- NP_000030
-
UniProt
- P02647
-
Pathways
- Regulation of Lipid Metabolism by PPARalpha, Production of Molecular Mediator of Immune Response, Lipid Metabolism
Target
-